Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer | NEJM
Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma - European Urology Focus
Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer in: Journal of the National Comprehensive Cancer Network Volume 15 Issue 10 (2017)
Frontiers | Prolonged neoadjuvant chemotherapy without radiation versus total neoadjuvant therapy for locally advanced rectal cancer: A propensity score matched study
Cancers | Free Full-Text | Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
Survival outcomes for dose‐dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple‐negative breast cancer: A prospective cohort study with propensity‐matched analysis - Xiu - 2022 -
Neoadjuvant Radio(chemo)therapy for Breast Cancer: An Old Concept Revisited | Semantic Scholar
Rethinking neoadjuvant chemotherapy for breast cancer | The BMJ
Nomogram Predicting Bladder Cancer–specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium - European Urology Focus
Treatment outcome in patients with stage III breast cancer treated with neoadjuvant chemotherapy
Survival outcomes after neoadjuvant letrozole and palbociclib versus third generation chemotherapy for patients with high-risk oestrogen receptor-positive HER2-negative breast cancer - ScienceDirect
Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint. | Semantic Scholar
Neutrophil–lymphocyte ratio reflects tumour‐infiltrating lymphocytes and tumour‐associated macrophages and independently predicts poor outcome in breast cancers with neoadjuvant chemotherapy - Li - Histopathology - Wiley Online Library
Comparison of outcomes between neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in patients with locally advanced esophageal cancer: A network meta-analysis - eClinicalMedicine
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
Locoregional Management After Neoadjuvant Chemotherapy | Journal of Clinical Oncology
Frontiers | The outcome of neoadjuvant chemotherapy and the current trend of surgical treatment in young women with breast cancer: A multicenter real-world study (CSBrS-012)
Cancers | Free Full-Text | Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine
Cureus | Neoadjuvant Therapy and Factors Influencing Survival in Locally Advanced Non-Small Cell Lung Cancer | Article
Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer - eClinicalMedicine
Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer: a contemporary analysis | Scientific Reports
Long-term Results After Neoadjuvant Chemotherapy for Breast Cancer: A Single-center Experience | Anticancer Research
Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC | Nature Cancer
Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR) | Breast Cancer Research | Full
Despite Equivalent Outcomes, Men Receive Neoadjuvant Chemotherapy Less Often Than Women for Lymph Node-Positive Breast Cancer | Annals of Surgical Oncology
